Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Binh Dinh Pharmaceutical And Medical Equipment JSC EBITDA Margin % Related Terms
Binh Dinh Pharmaceutical And Medical Equipment JSC EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC EBITDA Margin % Chart
Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Binh Dinh Pharmaceutical And Medical Equipment JSC's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Binh Dinh Pharmaceutical And Medical Equipment JSC EBITDA Margin % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a EBITDA Margin % of 23.57% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. This is 18% above median its historical median of 19.96. Over the past decade, Binh Dinh Pharmaceutical And Medical Equipment JSC's EBITDA Margin % has ranged from 16.82 to 22.59. According to the industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #284 out of 955 companies in the Drug Manufacturers industry, placing it in the top 29.7%.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's EBITDA Margin % too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current EBITDA Margin % of 23.57% is 18% above median its 10-year median of 19.96. Over the past 10 years, this metric has ranged from a low of 16.82 to a high of 22.59. The Drug Manufacturers industry median EBITDA Margin % is 12.44. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 23.57% is 89.5% above this industry median. Based on the distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #284 out of 955 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's EBITDA Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #284 out of 955 companies for EBITDA Margin %. This puts Binh Dinh Pharmaceutical And Medical Equipment JSC in the upper half of its industry. The industry median EBITDA Margin % is 12.44. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 23.57% is 89.5% above this benchmark. Historically, Binh Dinh Pharmaceutical And Medical Equipment JSC's own EBITDA Margin % has ranged from 16.82 to 22.59 over the past decade. While the company's 10-year median is 19.96 vs. the industry median of 12.44, Binh Dinh Pharmaceutical And Medical Equipment JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Binh Dinh Pharmaceutical And Medical Equipment JSC's current EBITDA Margin % of 23.57% is 89.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Binh Dinh Pharmaceutical And Medical Equipment JSC's current EBITDA Margin % is 23.57%, which is 18% above median its own 10-year median of 19.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,212.47, compared to a current price of ₫53,200.00 — trading 1.9% above its estimated fair value. The current EBITDA Margin % is 23.57%, which is 18% above median its 10-year median of 19.96 and 89.5% above the Drug Manufacturers industry median of 12.44. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current EBITDA Margin % is 23.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be overvalued.
The current stock price of ₫53,200.00 is trading 1.9% above its estimated GF Value™ of ₫52,212.47.
GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
EBITDA Margin %: 23.57% (18% above median its 10-year median of 19.96)
GF Value™: ₫52,212.47 vs. price of ₫53,200.00 (1.9% above fair value)
Industry Position: 89.5% above the Drug Manufacturers median (#284 of 955)
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
82GF Score
Get the complete analysis for STC:DBD
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DBD has been successfully added to your 
